US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist

38.540
-0.580-1.48%

Trading Apr 25 12:03 ET

4.90BMarket Cap18.35P/E (TTM)

Halozyme Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

25.62%829.25M

26.75%230.04M

3.38%216.03M

45.07%221.04M

38.25%162.14M

48.91%660.12M

77.93%181.5M

80.42%208.98M

11.66%152.37M

31.74%117.28M

Operating revenue

25.62%829.25M

26.75%230.04M

3.38%216.03M

45.07%221.04M

38.25%162.14M

48.91%660.12M

77.93%181.5M

80.42%208.98M

11.66%152.37M

31.74%117.28M

Cost of revenue

38.09%192.36M

24.16%52.3M

15.86%54.82M

47.51%50.07M

120.89%35.17M

71.11%139.3M

95.12%42.12M

154.55%47.32M

47.46%33.94M

-12.61%15.92M

Gross profit

22.29%636.89M

27.53%177.74M

-0.28%161.21M

44.37%170.97M

25.27%126.97M

43.91%520.81M

73.32%139.38M

66.24%161.66M

4.39%118.42M

43.15%101.36M

Operating expense

18.18%299.32M

18.25%76.71M

-6.93%72.93M

-9.31%76.51M

184.86%73.17M

194.53%253.28M

171.61%64.87M

261.88%78.37M

313.74%84.36M

28.00%25.69M

Selling and administrative expenses

3.94%149.18M

-0.37%37.61M

2.33%35.27M

-32.24%38.95M

170.04%37.36M

185.21%143.53M

174.06%37.75M

161.73%34.47M

366.49%57.48M

25.09%13.83M

Research and development costs

14.65%76.36M

-5.45%21.34M

3.69%17.32M

27.41%19.73M

51.68%17.98M

86.72%66.61M

123.25%22.57M

96.85%16.71M

91.88%15.48M

31.57%11.85M

Depreciation amortization depletion

70.98%73.77M

290.20%17.76M

-25.20%20.34M

56.41%17.84M

--17.84M

--43.15M

--4.55M

--27.19M

--11.4M

--0

-Depreciation and amortization

70.98%73.77M

290.20%17.76M

-25.20%20.34M

56.41%17.84M

--17.84M

--43.15M

--4.55M

--27.19M

--11.4M

--0

Operating profit

26.18%337.57M

35.60%101.04M

5.99%88.28M

177.33%94.46M

-28.90%53.8M

-3.03%267.53M

31.80%74.51M

10.20%83.29M

-63.39%34.06M

49.15%75.67M

Net non-operating interest income expense

-10.71%-18.76M

-14.22%-5.22M

40.05%-4.51M

-44.78%-4.49M

-158.27%-4.54M

-125.18%-16.95M

-122.38%-4.57M

-328.39%-7.51M

-77.17%-3.1M

10.48%-1.76M

Non-operating interest expense

10.71%18.76M

14.22%5.22M

-40.05%4.51M

44.78%4.49M

158.27%4.54M

125.18%16.95M

122.38%4.57M

328.39%7.51M

77.17%3.1M

-10.48%1.76M

Other net income (expense)

1,871.73%29.52M

529.11%5.36M

968.47%17.99M

437.78%3.19M

498.19%2.98M

91.61%-1.67M

157.40%852K

-855.84%-2.07M

-527.60%-945K

102.41%498K

Gain on sale of security

1,459.94%16.32M

529.11%5.36M

646.65%4.79M

437.78%3.19M

498.19%2.98M

-5.08%1.05M

157.40%852K

133.94%641K

-527.60%-945K

80.43%498K

Special income (charges)

586.73%13.2M

--0

586.73%13.2M

----

87.06%-2.71M

--0

---2.71M

----

-Less：Restructuring and merger&acquisition

---13.2M

--0

---13.2M

----

--0

----

-Less:Other special charges

----

-87.06%2.71M

--0

--2.71M

----

Income before tax

39.94%348.33M

42.92%101.18M

38.06%101.76M

210.41%93.16M

-29.80%52.24M

0.16%248.92M

29.16%70.79M

-0.54%73.71M

-67.21%30.01M

164.93%74.41M

Income tax

42.63%66.74M

20.61%15.79M

65.02%19.92M

151.19%18.4M

-11.73%12.62M

130.34%46.79M

209.44%13.09M

108.47%12.07M

12,531.03%7.33M

7,387.43%14.3M

Net income

39.31%281.59M

47.98%85.39M

32.78%81.84M

229.53%74.75M

-34.09%39.62M

-49.81%202.13M

-13.58%57.7M

-71.54%61.63M

-75.20%22.69M

115.48%60.11M

Net income continuous Operations

39.31%281.59M

47.98%85.39M

32.78%81.84M

229.53%74.75M

-34.09%39.62M

-49.81%202.13M

-13.58%57.7M

-71.54%61.63M

-75.20%22.69M

115.48%60.11M

Minority interest income

Net income attributable to the parent company

39.31%281.59M

47.98%85.39M

32.78%81.84M

229.53%74.75M

-34.09%39.62M

-49.81%202.13M

-13.58%57.7M

-71.54%61.63M

-75.20%22.69M

115.48%60.11M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

39.31%281.59M

47.98%85.39M

32.78%81.84M

229.53%74.75M

-34.09%39.62M

-49.81%202.13M

-13.58%57.7M

-71.54%61.63M

-75.20%22.69M

115.48%60.11M

Basic earnings per share

43.92%2.13

51.16%0.65

37.78%0.62

256.25%0.57

-34.09%0.29

-48.25%1.48

-10.42%0.43

-70.59%0.45

-75.00%0.16

120.00%0.44

Diluted earnings per share

45.83%2.1

54.76%0.65

38.64%0.61

250.00%0.56

-32.56%0.29

-47.45%1.44

-8.70%0.42

-70.27%0.44

-74.19%0.16

126.32%0.43

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	25.62%829.25M	26.75%230.04M	3.38%216.03M	45.07%221.04M	38.25%162.14M	48.91%660.12M	77.93%181.5M	80.42%208.98M	11.66%152.37M	31.74%117.28M
Operating revenue	25.62%829.25M	26.75%230.04M	3.38%216.03M	45.07%221.04M	38.25%162.14M	48.91%660.12M	77.93%181.5M	80.42%208.98M	11.66%152.37M	31.74%117.28M
Cost of revenue	38.09%192.36M	24.16%52.3M	15.86%54.82M	47.51%50.07M	120.89%35.17M	71.11%139.3M	95.12%42.12M	154.55%47.32M	47.46%33.94M	-12.61%15.92M
Gross profit	22.29%636.89M	27.53%177.74M	-0.28%161.21M	44.37%170.97M	25.27%126.97M	43.91%520.81M	73.32%139.38M	66.24%161.66M	4.39%118.42M	43.15%101.36M
Operating expense	18.18%299.32M	18.25%76.71M	-6.93%72.93M	-9.31%76.51M	184.86%73.17M	194.53%253.28M	171.61%64.87M	261.88%78.37M	313.74%84.36M	28.00%25.69M
Selling and administrative expenses	3.94%149.18M	-0.37%37.61M	2.33%35.27M	-32.24%38.95M	170.04%37.36M	185.21%143.53M	174.06%37.75M	161.73%34.47M	366.49%57.48M	25.09%13.83M
Research and development costs	14.65%76.36M	-5.45%21.34M	3.69%17.32M	27.41%19.73M	51.68%17.98M	86.72%66.61M	123.25%22.57M	96.85%16.71M	91.88%15.48M	31.57%11.85M
Depreciation amortization depletion	70.98%73.77M	290.20%17.76M	-25.20%20.34M	56.41%17.84M	--17.84M	--43.15M	--4.55M	--27.19M	--11.4M	--0
-Depreciation and amortization	70.98%73.77M	290.20%17.76M	-25.20%20.34M	56.41%17.84M	--17.84M	--43.15M	--4.55M	--27.19M	--11.4M	--0
Operating profit	26.18%337.57M	35.60%101.04M	5.99%88.28M	177.33%94.46M	-28.90%53.8M	-3.03%267.53M	31.80%74.51M	10.20%83.29M	-63.39%34.06M	49.15%75.67M
Net non-operating interest income expense	-10.71%-18.76M	-14.22%-5.22M	40.05%-4.51M	-44.78%-4.49M	-158.27%-4.54M	-125.18%-16.95M	-122.38%-4.57M	-328.39%-7.51M	-77.17%-3.1M	10.48%-1.76M
Non-operating interest expense	10.71%18.76M	14.22%5.22M	-40.05%4.51M	44.78%4.49M	158.27%4.54M	125.18%16.95M	122.38%4.57M	328.39%7.51M	77.17%3.1M	-10.48%1.76M
Other net income (expense)	1,871.73%29.52M	529.11%5.36M	968.47%17.99M	437.78%3.19M	498.19%2.98M	91.61%-1.67M	157.40%852K	-855.84%-2.07M	-527.60%-945K	102.41%498K
Gain on sale of security	1,459.94%16.32M	529.11%5.36M	646.65%4.79M	437.78%3.19M	498.19%2.98M	-5.08%1.05M	157.40%852K	133.94%641K	-527.60%-945K	80.43%498K
Special income (charges)	586.73%13.2M	--0	586.73%13.2M	----	----	87.06%-2.71M	--0	---2.71M	----	----
-Less：Restructuring and merger&acquisition	---13.2M	--0	---13.2M	----	----	--0	--0	--0	----	----
-Less:Other special charges	----	----	----	----	----	-87.06%2.71M	--0	--2.71M	----	----
Income before tax	39.94%348.33M	42.92%101.18M	38.06%101.76M	210.41%93.16M	-29.80%52.24M	0.16%248.92M	29.16%70.79M	-0.54%73.71M	-67.21%30.01M	164.93%74.41M
Income tax	42.63%66.74M	20.61%15.79M	65.02%19.92M	151.19%18.4M	-11.73%12.62M	130.34%46.79M	209.44%13.09M	108.47%12.07M	12,531.03%7.33M	7,387.43%14.3M
Net income	39.31%281.59M	47.98%85.39M	32.78%81.84M	229.53%74.75M	-34.09%39.62M	-49.81%202.13M	-13.58%57.7M	-71.54%61.63M	-75.20%22.69M	115.48%60.11M
Net income continuous Operations	39.31%281.59M	47.98%85.39M	32.78%81.84M	229.53%74.75M	-34.09%39.62M	-49.81%202.13M	-13.58%57.7M	-71.54%61.63M	-75.20%22.69M	115.48%60.11M
Minority interest income
Net income attributable to the parent company	39.31%281.59M	47.98%85.39M	32.78%81.84M	229.53%74.75M	-34.09%39.62M	-49.81%202.13M	-13.58%57.7M	-71.54%61.63M	-75.20%22.69M	115.48%60.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	39.31%281.59M	47.98%85.39M	32.78%81.84M	229.53%74.75M	-34.09%39.62M	-49.81%202.13M	-13.58%57.7M	-71.54%61.63M	-75.20%22.69M	115.48%60.11M
Basic earnings per share	43.92%2.13	51.16%0.65	37.78%0.62	256.25%0.57	-34.09%0.29	-48.25%1.48	-10.42%0.43	-70.59%0.45	-75.00%0.16	120.00%0.44
Diluted earnings per share	45.83%2.1	54.76%0.65	38.64%0.61	250.00%0.56	-32.56%0.29	-47.45%1.44	-8.70%0.42	-70.27%0.44	-74.19%0.16	126.32%0.43
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall